Livewire CEO to Shareholders on OTCQB Up-listing
I know it has been a while since we announced that we were planning to up-list to OTCQB in November of last year and we realize it has taken longer than anticipated. We had researched the requirements for up-listing to OTCQB and based on our findings, we moved ahead with our application, expecting a relatively smooth and timely process. In December of 2018 we posted audited financials for 2016 and 2017 and filed our OTCQB Certification application as required by OTC Markets.
In January of 2019 we filed our quarterly report for Q3 2018 and additional QB supporting documents for a final review by OTC Markets, as required before final approval of our up-listing application. After the review by OTC we were informed that certain disclosures formatting needed to be amended and reposted.
Due to timing deadlines for the filing of our Annual Report 2018, we had to decide on whether to continue making the requested changes to the quarterly report or prepare and file our audited annual report, since we fully expected that OTC would now request the Annual Report to back up our application for up-listing. We chose to focus on the annual report and to post the unaudited financials while the audit is getting finalized. We’re confident that our reapplication combined with the audited Annual Report for 2018 will meet the requirements for OTCQB up-listing, and I’m hopeful that this will take place in the next 60 days.
We will follow up soon with more detail on our business projects that are currently in the making and moving along nicely.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. specializes in identifying and monetizing current and future trends in the health and wellness industry, with a focus on the cannabis sector. The Company acquires, manages and licenses specialized real estate locations for fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California. Through its subsidiary GHC Ventures it has been awarded several permits for the Company’s nursery locations in California as well as a Statewide distribution license. The Company is also entering into research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes dosing verification of zero-pesticide products for quality brands via the Company’s “7X Pure” Cannabis Dosing and Verification System, and development and licensing of legal, high-quality cannabinoid-based products and services. LiveWire Ergogenics does not sell or distribute products that are in violation of the Unites States Controlled Substance Act.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results and performance, events or circumstances, and actual events may differ materially. Factors that may cause actual results to differ materially from any projections may include, without limitation, delays in the development of its products, the impact of significant new or changing government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s inability to obtain additional financing for the implementation of the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.
